FOLLOWUS
Development of clinical practice guidelines in 11 common diseases with Chinese medicine interventions in China
Development of clinical practice guidelines in 11 common diseases with Chinese medicine interventions in China
- 中国结合医学杂志（英文版） 2012年18卷第2期 页码：112-119
- Affiliations：
Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences,Beijing,China
- Author bio：
- Funds：Supported by National Natural Science Foundation of China (No. 30825047), the Projects from State Administration of Traditional Chinese Medicine (No. ZYYS-2008), and China Academy of Chinese Medical Sciences (No. Z0135 and Z02128 and Z02114)
DOI：10.1007/s11655-012-0997-y
中图分类号：纸质出版日期：2012，
网络出版日期：2012-2-5，
Scan for full text
Yuwen, Y., Shi, Nn., Wang, Ly. et al. Development of clinical practice guidelines in 11 common diseases with Chinese medicine interventions in China., Chin. J. Integr. Med. 18, 112–119 (2012). https://doi.org/10.1007/s11655-012-0997-y
Ya Yuwen, Nan-nan Shi, Li-ying Wang, et al. Development of clinical practice guidelines in 11 common diseases with Chinese medicine interventions in China[J]. Chinese Journal of Integrative Medicine, 2012,18(2):112-119.
Yuwen, Y., Shi, Nn., Wang, Ly. et al. Development of clinical practice guidelines in 11 common diseases with Chinese medicine interventions in China., Chin. J. Integr. Med. 18, 112–119 (2012). https://doi.org/10.1007/s11655-012-0997-y DOI：
Ya Yuwen, Nan-nan Shi, Li-ying Wang, et al. Development of clinical practice guidelines in 11 common diseases with Chinese medicine interventions in China[J]. Chinese Journal of Integrative Medicine, 2012,18(2):112-119. DOI： 10.1007/s11655-012-0997-y.
摘要
To analyze the clinical practice guideline (CPG) development on 11 common diseases with Chinese medicine (CM) interventions in China. The CPGs of 11 common diseases which could be treated effectively with CM had been published between 1980 and 2010 in China. The 11 diseases include coronary heart disease (angina pectoris)
hypertension
chronic gastritis
rheumatoid arthritis
cerebral infarction
migraine
diabetes
primary osteoporosis
insomnia
common cold
and IgA nephropathy. The issuing organization
date of publication
development methods
and citation rate of the CPGs were analyzed. According to the development method
each guideline was categorized as consensus-based (CB)
evidence-based (EB)
or consensus based with no explicit consideration of evidence-based (CB-EB). Thirty-three CPGs on the 11 common diseases were found: 20 guidelines were classified as CB
13 as CB-EB and none as EB. Fifteen CPGs were issued by the China Association of Chinese Medicine
8 by professional working groups
and 4 by the State Administration of Traditional Chinese Medicine. Six guidelines were published between 1980 and 1990
9 between 1991 and 2000
and 18 between 2001 and 2010. Fifty-eight percent of these guidelines have not been amended timely. Only 54.5% (18/33) of the 33 guidelines were cited by other researchers and 45.5% (15/33) percent had never been cited. Most CPGs developed for 11 common diseases with CM approaches in China are consensus
and their citation rates are relatively low. The results suggest that more EB CPG or CPG strictly based on expert consensus could be developed
and great efforts should be made for future CM CPG application.
Abstract
To analyze the clinical practice guideline (CPG) development on 11 common diseases with Chinese medicine (CM) interventions in China. The CPGs of 11 common diseases which could be treated effectively with CM had been published between 1980 and 2010 in China. The 11 diseases include coronary heart disease (angina pectoris)
hypertension
chronic gastritis
rheumatoid arthritis
cerebral infarction
migraine
diabetes
primary osteoporosis
insomnia
common cold
and IgA nephropathy. The issuing organization
date of publication
development methods
and citation rate of the CPGs were analyzed. According to the development method
each guideline was categorized as consensus-based (CB)
evidence-based (EB)
or consensus based with no explicit consideration of evidence-based (CB-EB). Thirty-three CPGs on the 11 common diseases were found: 20 guidelines were classified as CB
13 as CB-EB and none as EB. Fifteen CPGs were issued by the China Association of Chinese Medicine
8 by professional working groups
and 4 by the State Administration of Traditional Chinese Medicine. Six guidelines were published between 1980 and 1990
9 between 1991 and 2000
and 18 between 2001 and 2010. Fifty-eight percent of these guidelines have not been amended timely. Only 54.5% (18/33) of the 33 guidelines were cited by other researchers and 45.5% (15/33) percent had never been cited. Most CPGs developed for 11 common diseases with CM approaches in China are consensus
and their citation rates are relatively low. The results suggest that more EB CPG or CPG strictly based on expert consensus could be developed
and great efforts should be made for future CM CPG application.
关键词
clinical practice guidelinemethodologyChinese Medicine
Keywords
clinical practice guidelinemethodologyChinese Medicine
references
Scottish Intercollegiate Guidelines Network. SIGN 50: a guideline developers handbook. http://www.sign.ac.uk/guidelines/fulltext/50.
Cruse H, Winiarek M, Marshburn J, Clark O, Djulbegovic B. Quality and methods of developing practice guidelines. BMC Health Serv Res 2002;2:1–7.
New Zealand Guidelines Group. Handbook for the preparation of explicit evidence-based clinical practice guidelines. New Zealand Guidelines Group 2001:1–157.
Association of Community Cancer Centers. Oncology patient management guidelines. Breast Carcinoma Version 3.0 ACCC 1999.
Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer. Clinical practice guidelines for the care and treatment of breast cancer: 8. Adjuvant systemic therapy for women with node-positive breast cancer. Can Med Assoc J 1998;158(3 Suppl):S52–S64.
Update: NCCN practice guidelines for the treatment of breast cancer. National Comprehensive Cancer Network. Oncology (Williston park) 1999;13(5A):41–66.
National Research Symposium on Coronary Heart Disease Pattern Differentiation. Coronary heart disease syndrome differention standard for Chinese medicine. J Tradit Chin Med (Chin) 1980;21(8):46.
Stroke Council of Society of Internal Medicine, China Association of Chinese Medicine. Standard for diagnosis and efficacy evaluation of stroke with Chinese medicine. China J Tradit Chin Med Pharm (Chin) 1986;1(2):56.
Working Group of TCM Diagnostic Criterion for Disease Name. Standard for diagnosis of disease name with Chinese medicine. Changsha: Hunan Academy of Chinese medicine; 1987:1–661.
Society of Internal Medicine of China Association of Traditional Chinese Medicine. Standard for the diagnosis and efficacy evaluation of cardiac obstruction. China J Tradit Chin Med Pharm (Chin) 1988;3(2):66.
China Professional Committee of Chinese and Western Medicine with Digestive System. Standard for diagnosis, syndrome differention and efficacy of chronic gastritis with integrated traditional and Western medicine. Chin J Integr Tradit West Med (Chin) 1990;10:318–319.
Traditional Chinese Medicine & emergency Collaborative Group. Standard for diagnosis and treatment of emergency syndrome of thoracic obstruction heartache. State Administration Tradit Chin Med (Chin) 1990:64–74.
State Administration of Traditional Chinese Medicine. Standard for diagnosis and efficacy of Chinese medicine syndrome. Nanjing: Nanjing University Publishing House; 1994:1–326.
Collaborative Group of Cerebral Emergency Research of State Administration of Traditional Chinese Medicine. Standard for pattern differentiation of stroke (Trial). J Beijing Univ Tradit Chin Med (Chin) 1994;17(3):64–65.
Traditional Chinese Medicine & emergency Collaborative Group. Standard for diagnosis and treatment of Chinese medicine internal emergency. State Administration Tradit Chin Med (Chin) 1994:1–107.
Professional Committee of Rheumatism, China Association of Chinese Medicine. Standard for diagnosis and pattern differentiation of Wangbi. Conference Proceeding (Chin) 1996.
Collaborative Group of Cerebral Emergency of State Administration of Traditional Chinese Medicine. Standard for diagnosis and efficacy evaluation of stroke (Trial). J Beijing Univ Tradit Chin Med (Chin) 1996;19(1):55–56.
State Bureau of Technical Supervision. Clinical diagnosis and treatment terminology of Chinese medicine. Beijing: China Standard Press; 1997:1–103.
Collaborative Group of Emergency of State Administration of Traditional Chinese Medicine. Head wind disease syndrome diagnostic criteria. J Beijing Univ Tradit Chin Med (Chin) 1997;20(4):48–49.
IgA Nephropathy Collaboration Center of China Professional Committee for Nephropathy with Traditional Chinese Medicine. Standard for efficacy evaluation of IgA nephropathy. Conference Proceeding (Chin) 1998.
Osteoporosis Working Group of Osteoporosis Committee of China Association of Gerontology. Suggestion on diagnostic criteria of osteoporosis for Chinese (2nd ed). Chin J Osteoporos (Chin) 2000;6:1–3.
Shen SG, Wang CD, Yan XJ. Standard for diagnosis, efficacy and treatment of heart disease with Chinese medicine. Beijing: Beijing Publishing House of Science and Technology; 2002:1–179.
State Food and Drug Administration. Guiding principle of clinical researches on new drugs of traditional Chinese medicine. Beijing: China Medical Science and Technology Press; 2002:53–392.
Diabetes professional committee of China Association of Integrated Chinese and Western Medicine. Standard for diagnosis and therapeutic efficacy evaluation of diabetes mellius in integrative Chinese and Western medicine. Chin J Integr Tradit West Med (Chin) 2005;25:94–95.
Expert Consensus Group of Definitions, Diagnosis and Treatment with Drugs of Insomnia. Guideline for definitions, diagnosis and treatment with drugs of insomnia (draft). Chin J Neurol (Chin) 2006;2:141–143.
Guideline Developing Group. A guideline for pre-clinical and clinical assessment on prevention and treatment of osteoporosis with traditional Chinese drugs. Beijing: People’s Medical Publishing House; 2006:1–77.
China Association of Chinese Medicine. Guidelines for Chinese medicine diabetes prevention and treatment. Beijing: China Press of Traditional Chinese Medicine; 2007:1–87.
Nephropathy Committee of China Association of Chinese Medicine. Standard for diagnosis, syndrome type and efficacy assessment of IgA nephropathy. Shanghai J Trad Chin Med (Chin) 2007;41(5):9–10.
China Association of Chinese Medicine. Guidelines for diagnosis and treatment of common internal diseases in Chinese medicine disease of modern medicine. Beijing: China Press of Traditional Chinese Medicine; 2008:1–305.
China Association of Chinese Medicine. Guidelines for diagnosis and treatment of common internal diseases in Chinese medicine symptoms in Chinese medicine. Beijing: China Press of Traditional Chinese Medicine; 2008:1–147.
Song J, Chen KJ. Set clinical therapeutic guideline in traditional medicine urgently. Chin J Integr Tradit West Med (Chin) 2006;26:581–584.
Antman EM, Lau J, Kupelnick B, Mosteller F, Chalmers TC. A comparison of results of meta-analyses of randomized controlled trials and recommendations of clinical experts: treatments for myocardial infarction. JAMA 1992;268:240–248.
Mulrow CD. Systematic reviews: rationale for systematic reviews. BMJ 1994;309:597–599.
Field M, Lohr K. Institute of Medicine Committee to Advise the Public Health Service on Clinical Practice Guidelines. Clinical practice guidelines: direction for a new program. Washington DC: National Academy Press; 1990:1–160.
Canadian Medical Association. Guidelines for Canadian clinical practice guidelines [2007-5-8]. http://mdm.ca/cpgsnew/cpgs/gccpg-e.htm.
Jin ZC. Problems in establishing clinical guideline for integrated traditional Chinese and Western medicine. J Chin Integr Med (Chin) 2008;6:5–8.
Institute of Medicine. Guideline for clinical practice: from development to use. Washington DC: National Academic Press; 1992:1–241.
Appraisal of Guidelines for Research & Evaluation (AGREE) Instrument. http://www.agreecollaboration.iorg/instrument.
Vlayen J, Aertgeerts B, Hannes K, Sermeus W, Ramaekers D. A systematic review of appraisal tools for clinical practice guidelines: multiple similarities and one common deficit. Intern J Quality Health Care 2005;17:235–242.
0
浏览量
93
Downloads
13
CSCD
- Meta-XML下载
- BibTeX下载
- Endnote下载
- RefMan 下载
- NoteExpress下载
- NoteFirst下载
关联资源
相关文章
相关作者
相关机构
- 邮编：100091
- 联系电话：010-62886827, 62877592 传真：010-62874291
- 技术支持由北京北大方正电子有限公司提供 京ICP备05067934号-1
京公网安备11010802024621 - 本系统建议在Chrome、 IE9+ 以上版本浏览器阅读本站内容，360浏览器请切换至极速模式
- Cookies帮助我们提供服务并提供个性化体验。使用本网站，即表示您同意我们使用Cookies
